ANNUAL REPORT FOR YEAR ENDED JULY 31, 2009

Company

Sunshine Biopharma Inc.

Filed

October 30, 2009

Period of Report

July 31, 2009

Accession Number

0001079974-09-000803

A 10-K is a company's comprehensive annual report, required by the SEC. It includes audited financial statements, a description of the business, risk factors, and management's discussion of results. Learn more about 10-K filings →